Baraga County Home Care & Hospice 510 Memorial Street, Suite A, L Anse, MI, 49946 | |
(906) 524-4663 |
News Archive
Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.
By reviewing published literature on viral loads and viral shedding, researchers found that viral loads for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)peak before symptoms are seen. This has substantial implications for prevention strategies.
Today the humanitarian organization CARE applauds the United States' leadership in addressing long-term solutions to global hunger. CARE commends Chairman John Kerry (D-MA) and Ranking Member Richard Lugar (R-IN) for holding this important hearing.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
› Verified 8 days ago
Name | Baraga County Home Care & Hospice |
---|---|
Location | 510 Memorial Street, Suite A, L Anse, Michigan |
Hospice ID | 231586 |
Category | Part of a Home Health Agency |
Ownership Type | Government - County |
Profit Type | GEVERNMENT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 060 |
News Archive
Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.
By reviewing published literature on viral loads and viral shedding, researchers found that viral loads for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)peak before symptoms are seen. This has substantial implications for prevention strategies.
Today the humanitarian organization CARE applauds the United States' leadership in addressing long-term solutions to global hunger. CARE commends Chairman John Kerry (D-MA) and Ranking Member Richard Lugar (R-IN) for holding this important hearing.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
› Verified 8 days ago
NPI Number | 1457459059 |
Organization Name | Baraga County Memorial Hospital |
Address | 510 Memorial St Lanse, Michigan, 49946 |
Phone Number | (906)524-4663 |
News Archive
Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.
By reviewing published literature on viral loads and viral shedding, researchers found that viral loads for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)peak before symptoms are seen. This has substantial implications for prevention strategies.
Today the humanitarian organization CARE applauds the United States' leadership in addressing long-term solutions to global hunger. CARE commends Chairman John Kerry (D-MA) and Ranking Member Richard Lugar (R-IN) for holding this important hearing.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.
By reviewing published literature on viral loads and viral shedding, researchers found that viral loads for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)peak before symptoms are seen. This has substantial implications for prevention strategies.
Today the humanitarian organization CARE applauds the United States' leadership in addressing long-term solutions to global hunger. CARE commends Chairman John Kerry (D-MA) and Ranking Member Richard Lugar (R-IN) for holding this important hearing.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
› Verified 8 days ago
Home Health Aides | 1.5 |
Homemakers | 0.01 |
Medical Social Workers | 0.1 |
Physicians | 0.05 |
Registered Nurses | 5.3 |
Other Personnel | 1.1 |
Total Employees | 8.06 |
---|
News Archive
Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.
By reviewing published literature on viral loads and viral shedding, researchers found that viral loads for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)peak before symptoms are seen. This has substantial implications for prevention strategies.
Today the humanitarian organization CARE applauds the United States' leadership in addressing long-term solutions to global hunger. CARE commends Chairman John Kerry (D-MA) and Ranking Member Richard Lugar (R-IN) for holding this important hearing.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
› Verified 8 days ago
Counselors | 0.05 |
Others | 4 |
Total Volunteers | 4.05 |
---|
News Archive
Absorption Systems LP today announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant from the U.S. Food and Drug Administration (FDA) to continue development of the company's CellPort Technologies™ testing platform. This unique assay platform enables more specific prediction of potential drug-drug interactions mediated by human drug transport proteins.
By reviewing published literature on viral loads and viral shedding, researchers found that viral loads for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)peak before symptoms are seen. This has substantial implications for prevention strategies.
Today the humanitarian organization CARE applauds the United States' leadership in addressing long-term solutions to global hunger. CARE commends Chairman John Kerry (D-MA) and Ranking Member Richard Lugar (R-IN) for holding this important hearing.
Thoratec Corporation, a manufacturer of products to treat cardiovascular disease, has announced the expansion of its Phase I feasibility trial for the HeartMate(R) II left ventricular assist system (LVAS).
Librede Inc. has joined the UCLA on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening.
› Verified 8 days ago
Baraga County Home Care & Hospice Location: 510 Memorial Street, Suite A, L Anse, Michigan, 49946 Phone: (906) 524-4663 |